Acadia Healthcare enters $1.65 billion credit agreement, replacing its 2021 facility
Acadia Healthcare entered a new credit agreement with JPMorgan Chase Bank as administrative agent, providing a $1 billion revolving facility and a $650 million term loan, both maturing February 28, 2030. The company used the proceeds to refinance obligations under its prior credit agreement, which it terminated, and the new facilities carry floating interest rates and financial covenants.
Key points
- New $1 billion revolving facility and $650 million term loan, both maturing February 28, 2030
- Proceeds used to refinance obligations under the Existing Credit Agreement, which was dated March 17, 2021 and scheduled to mature March 17, 2026
- Borrowings bear floating rates: SOFR plus 1.375% to 2.250%, or base rate plus 0.375% to 1.250%, based on net leverage
- Covenants include a Consolidated Total Net Leverage Ratio of no more than 5.0 to 1.0 and Interest Coverage of at least 3.0 to 1.0
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 7:03 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 28, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.